论文信息 - TGF‐β‐activated kinase‐1 inhibitor LL‐Z1640‐2 reduces joint inflammation and bone destruction in mouse models of rheumatoid arthritis by inhibiting NLRP3 inflammasome, TACE, TNF‐α and RANKL expression - 字舞流文

TGF‐β‐activated kinase‐1 inhibitor LL‐Z1640‐2 reduces joint inflammation and bone destruction in mouse models of rheumatoid arthritis by inhibiting NLRP3 inflammasome, TACE, TNF‐α and RANKL expression

I. Endo | H. Sakaue | Toshio Matsumoto | K. Tanimoto | M. Abe | E. Tanaka | M. Hiasa | A. Oda | R. Tsutsumi | J. Teramachi | K. Sogabe | Tomoko Maruhashi | T. Harada | Ryohei Sumitani | M. Oura | Tomoyo Hara | Hirofumi Tenshin | Mayu Sebe | Yusuke Inoue | Mohannad Ashtar | So Shimizu | Yoshiki Higa | Asuka Oda